Journals / Bozok Veterinary Sciences / 2021 / Cilt: 2 - Sayı: 2

Some Immunosuppressive Drugs Used in Cats and Dogs and Their Purposes

Kedi ve Köpeklerde Kullanılan Bazı İmmünsupresif İlaçlar ve Kullanım Amaçları

Pages
101–107
Publication Date
2021-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the general characteristics of some immunosuppressive drugs that are most used in small animal medicine and the situations in which they are used are given in the light of the current literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The immune system is a system that protects the organism against diseases by recognizing tumor cells and pathogenic agents.
📊
Key Findings & Data:Immunosuppressive therapy is used in organ transplants, some inflammatory and autoimmune diseases.
💡
Conclusion & Impact:In this review, the general characteristics of some immunosuppressive drugs that are most used in small animal medicine and the situations in which they are used are given in the light of the current literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:İmmün sistem · İmmünsupresif ilaçlar · İmmünmodulatör

Abstract

The immune system is a system that protects the organism against diseases by recognizing tumor cells and pathogenic agents. Immunosuppressive therapy is used in organ transplants, some inflammatory and autoimmune diseases. The balance of the immune system is regulated by suppressing and increasing the immune system. Immunosuppressive drugs are divided into nonspecific [(radiation, corticosteroids, cytotoxic drugs (alkylating agents, folic acid antagonists, DNA synthesis inhibitors]) and selective immunosuppressants (calcineurin inhibitors, rapamycin inhibitors, inosine monophosphate dehydrogenase inhibitors, leflunomide, lymphocyte depletion treatment, intravenous immunglobulin therapy) according to their mode of action. Immunosuppressive drugs can be used alone or as combined drug therapy. In this review, the general characteristics of some immunosuppressive drugs that are most used in small animal medicine and the situations in which they are used are given in the light of the current literature.

Özet

İmmün sistem tümör hücrelerini ve patojen ajanları tanıyarak hastalıklara karşı organizmayı koruyan bir sistemdir. Organ nakillerinde, bazı yangısal ve otoimmun hastalıklarda immünsupresif tedavi kullanılmaktadır. İmmün sistemin dengesi immün sistemin baskılanması ve artırılması şeklinde düzenlenmektedir. İmmünsupresif ilaçlar etki şekillerine göre nonspesifik immünsupresyon oluşturanlar [(radyasyon, kortikosteroidler, sitotoksik ilaçlar (alkilleyici ajanlar, folik asit antagonistleri, DNA sentez inhibitörleri]) ve seçici immünsupresyon oluşturanlar (kalsinörin inhibitörleri, rapamisin inhibitörleri, inosin monofosfat dehidrojenaz inhibitörleri, leflunomide, lenfosit deplesyon tedavisi, intravenöz immunglobulin tedavisi) olarak ikiye ayrılmaktadır. İmmünsupresif ilaçlar tek başlarına kullanılabileceği gibi kombine ilaç tedavisi şeklinde de kullanılabilmektedir. Bu derlemede küçük hayvan hekimliğinde en fazla kullanılan bazı immünsupresif ilaçların genel özellikleri ve kullanıldığı durumlar güncel literatürler ışığında bilgi verilmiştir.

🔖

Cite This Article

AYDIN, Ö., AKTAŞ, M. S. (2021). Some Immunosuppressive Drugs Used in Cats and Dogs and Their Purposes. Bozok Veterinary Sciences, Cilt: 2 - Sayı: 2, 101–107. https://ajindex.com/articles/850677

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Chinen J, Finkelman F, Shearer WT. Advances in basic and clinical immunology. Journal of Allergy and Clinical Immunology 2006; 118: 489-495. doi: 10.1016/j.jaci.2006.05.021
  2. Chatzinasiou E, Chaintoutis SC, Dovas CI, Papanastassopoulou M, Papadopoulos O. Immunosuppression in sheep induced by cyclophosphamide, bluetongue virus and their combination: Effect on clinical reaction and viremia. Microb Pathogenesis 2017; 104: 318-327. doi: 10.1016/j.micpath.2017.01.048
  3. Rathee P, Chaudhary H, Rathee S, Rathee D, Kumar V. Immunosuppressants: A Review. The Pharma Innovation 2012; 1: 90
  4. Saroj P, Verma M, Jha KK, Pal M. An owerview on immunomodilation. Journal of Advanced Scientific Research 2012; 3: 7-12
  5. Tizard IR. Veterinary Immunology. Ninth Edition. St. Louis: Elsevier Saunders, 2013; p. 468-473
  6. Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology Biology Physics 1995; 31: 1319-1339. doi: 10.1016/0360-3016(94)00430-S
  7. Schwarz A, Noordegraaf M, Maeda A, Torii K, Clausen BE, et al. Langerhans cells are required for UVR-induced immunosuppression. Journal of Investigative Dermatology 2010; 130: 1419-1427. doi: 10.1038/jid.2009.429
  8. Rana S, Rogers LJ, Halliday GM. Systemic low-dose UVB inhibits CD8 T cells and skin inflammation by alternative and novel mechanisms. American Journal of Pathology 2011; 178: 2783-2791. doi: doi.org/10.1016/j.ajpath.2011.02.016
  9. Giuliano A, Dobson J. Clinical response and survival time of cats with carcinoma of the nasal cavity treated with palliative coarse fractionated radiotherapy. Journal of Feline Medicine and Surgery 2020; 22: 922-927. doi: 10.1177/1098612X19893445
  10. Moore AS. Radiation therapy for the treatment of tumours in small companion animals. The Veterinary Journal 2002; 164: 176-187. doi: 10.1053/tvjl.2002.0728
  11. Marino IR, Doyle HR. Conventional immunosuppressive drugs. Thomson AW, Starzl TE, Arnold E. eds. In: Immunosuprressive Drugs: Developments in Anti-Rejection Therapy. London: Hodder Education Publisher; 1994. pp.1-256
  12. Spoelhof B, Ray SD. Corticosteroids. Encyclopedia of Toxicology 2014; 1:1038-1042. doi: doi.org/10.1016/B978-0-12-386454-3.00293-1
  13. Barshes NR, Goodpastor SE, Goss JA. Pharmacologic immunosuppression. Frontiers in Bioscience 2004; 9: 411-420. doi: 10.2741/1249
  14. Bavaresco I, Bernardi A, Battastini AMO. Gl